These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 19170724

  • 1. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Pronko TP, Zinchuk VV.
    Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
    Buval'tsev VI, Spasskaia MB, Nebieridze DV, Metel'skaia VA, Guseva OI.
    Klin Med (Mosk); 2003 May; 81(7):51-5. PubMed ID: 12934313
    [Abstract] [Full Text] [Related]

  • 3. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A, Popov D, Dragan E, Dragomir E, Badila E.
    Eur J Pharmacol; 2007 Sep 10; 570(1-3):149-58. PubMed ID: 17612521
    [Abstract] [Full Text] [Related]

  • 4. Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients.
    Kaiser T, Heise T, Nosek L, Eckers U, Sawicki PT.
    J Hypertens; 2006 Jul 10; 24(7):1397-403. PubMed ID: 16794490
    [Abstract] [Full Text] [Related]

  • 5. [Cardiorenal pathology in diabetes mellitus type 1: mechanisms of development and medical correction].
    Shestakov MV, Iarek-Martynova IR, Kukharenko SS, Aleksandrov AA, Dedov II.
    Ter Arkh; 2005 Jul 10; 77(6):40-5. PubMed ID: 16078599
    [Abstract] [Full Text] [Related]

  • 6. Nitric oxide mechanisms of nebivolol.
    Maffei A, Lembo G.
    Ther Adv Cardiovasc Dis; 2009 Aug 10; 3(4):317-27. PubMed ID: 19443516
    [Abstract] [Full Text] [Related]

  • 7. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
    Gupta S, Wright HM.
    Cardiovasc Ther; 2008 Aug 10; 26(3):189-202. PubMed ID: 18786089
    [Abstract] [Full Text] [Related]

  • 8. Targeting endothelial dysfunction in hypertensive subjects.
    Thuillez C, Richard V.
    J Hum Hypertens; 2005 Jun 10; 19 Suppl 1():S21-5. PubMed ID: 16075029
    [Abstract] [Full Text] [Related]

  • 9. Impact of nebivolol on levels of serum nitric oxide, plasma von Willebrand factor and exercise stress testing parameters in hypertensive and ischemic heart disease patients.
    Kobusiak-Prokopowicz M, Jołda-Mydłowska B, Zubkiewicz A, Szymczak M, Mysiak A, Skalik R.
    Cardiol J; 2008 Jun 10; 15(2):162-8. PubMed ID: 18651401
    [Abstract] [Full Text] [Related]

  • 10. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D, Papademetriou V.
    Expert Rev Cardiovasc Ther; 2008 Apr 10; 6(4):471-9. PubMed ID: 18402537
    [Abstract] [Full Text] [Related]

  • 11. Blood oxygen transport and endothelial dysfunction in patients with arterial hypertension.
    Zinchuk VV, Pronko TP, Lis MA.
    Clin Physiol Funct Imaging; 2004 Jul 10; 24(4):205-11. PubMed ID: 15233834
    [Abstract] [Full Text] [Related]

  • 12. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar 10; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J, Faulhaber HD.
    Praxis (Bern 1994); 2001 Mar 15; 90(11):435-41. PubMed ID: 11293936
    [Abstract] [Full Text] [Related]

  • 15. [Dynamics of a 24-h profile of arterial pressure and function of the vascular endothelium in nebivolol treatment of hypertensive patients].
    Gel'tser BI, Kotel'nikov VN.
    Klin Med (Mosk); 2003 Mar 15; 81(8):53-6. PubMed ID: 14520947
    [Abstract] [Full Text] [Related]

  • 16. [Effect of enape combined with nebilet in hypertension].
    Gol'drin EN, Samokhina LM.
    Lik Sprava; 2002 Mar 15; (7):104-7. PubMed ID: 12587324
    [Abstract] [Full Text] [Related]

  • 17. Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activity.
    Mason RP, Kubant R, Jacob RF, Walter MF, Boychuk B, Malinski T.
    J Cardiovasc Pharmacol; 2006 Jul 15; 48(1):862-9. PubMed ID: 16891916
    [Abstract] [Full Text] [Related]

  • 18. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A, Uzunlulu M, Yorulmaz E, Yalçin Y, Hekim N, Fici F.
    Anadolu Kardiyol Derg; 2007 Dec 15; 7(4):383-7. PubMed ID: 18065333
    [Abstract] [Full Text] [Related]

  • 19. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
    Tzemos N, Lim PO, MacDonald TM.
    Circulation; 2001 Jul 31; 104(5):511-4. PubMed ID: 11479245
    [Abstract] [Full Text] [Related]

  • 20. [Nebivolol effects on the cardiovascular system and the kidneys in pregnant and puerperal women with hypertension].
    Tkacheva ON, Vertkin AL, Barabashkina AV, Vasil'eva AV, Razguliaeva NF.
    Ter Arkh; 2006 Jul 31; 78(10):56-61. PubMed ID: 17180940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.